Sinuva (Mometasone Furoate) & Cataracts, Diminished Visual Acuity, Glaucoma, and Nasal Septal Perforation

    Basic Details
    Status
    Ongoing
    Last Updated
    Monday, December 18, 2017
    Health Outcome(s)
    cataracts
    diminished visual acuity
    glaucoma
    nasal septal perforation
    Purpose
    Drug and Outcome Analysis
    Regulatory Determination / Use

    Feasibility assessment of ARIA sufficiency to replace a sponsor postmarketing requirement (PMR) safety study for Sinuva (mometasone furoate)